Katsuya Nagaoka

16PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - nucleic acidsMetabolic medicineMedical devicesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 18, 2026
Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational Study.

Yoko Yoshimaru, Katsuya Nagaoka, Hiroko Setoyama

|Feb 18, 2026
Correction for Suzuki et al., "Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion".

Takanori Suzuki, Chiharu Ohue, Osamu Arai

|Nov 05, 2025
The Role of an Elevated Fibrosis-4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Maiko Nagaoka, Katsuya Nagaoka, Naoto Kajitani

|Aug 19, 2025
Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion.

Takanori Suzuki, Chiharu Ohue, Osamu Arai

|May 03, 2025
Serum alpha-fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis.

Hiroki Inada, Katsuya Nagaoka, Kenyu Hashimoto

|Mar 31, 2025
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease.

Hongze Chen, Muhammad Azhar Nisar, Joud Mulla

Pageof 3

Frequent Collaborators

11 joint publications

Yasuhito Tanaka

4 joint publications

Takehisa Watanabe

4 joint publications

Takayuki Tokunaga

4 joint publications

Hiroki Inada